Aebi Schmidt amends relationship agreement; PCS Holding gets board seats tied to ownership

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On May 27, 2026, OSR Holdings, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Vaximm AG (“Vaximm”), a clinical-stage biopharmaceutical company organized under the laws of Switzerland.

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On June 1, 2026, Virtuix Holdings Inc. (the “Company”) entered into amendments to each of the following warrants to purchase shares of Class A Common Stock (collectively, the “Warrant Amendments”) with Streeterville Capital, LLC (the “Investor”) amending the exercise price and extending the Reduced Exercise Price Period (as defined below) to each such warrant

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On June 2, 2026, Curbline Properties Corp. (the “ Company ”) and Curbline Properties LP (the “ Operating Partnership ”) entered into an ATM Equity Offering Sales Agreement (the “ Equity Sales Agreement ”) with Jefferies LLC, BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, Nomura Securities International, Inc., StoneX Financial Inc. and Wells Fargo Securities, LLC, as sales agents

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On May 27, 2026, Bluejay Diagnostics, Inc. (the “Company”) entered into an agreement and statement of work (together, the “Agreement”) with Argonaut Manufacturing Services c/o Argonaut, Inc. (“Argonaut”) regarding the provision by Argonaut to the Company of certain manufacturing services to support the Company’s SymphonyTM platform.

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On May 28, 2026, in connection with the pricing of the Offering, the Company entered into an underwriting agreement (the "Underwriting Agreement") with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Jefferies LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters listed on Schedule I thereto

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On June 2, 2026, Genco Shipping & Trading Limited (the “ Company ”) entered into the Third Amendment to Shareholders Rights Agreement (the “ Third Amendment ”) to amend the Shareholder Rights Agreement, dated as of October 1, 2025 between the Company and Computershare Inc., as amended to date (the “ Rights Agreement ”).

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock

This filing

On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.

Comparable filing

On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).